Joline receives FDA approval for kyphoplasty products

Joline GmbH & Co. KG announces that the company has obtained premarket approval from the US Food and Drug Administration (FDA) for Joline kyphoplasty products to treat vertebral compression fractures.

With FDA approval for our kyphoplasty products, we can now offer patients in the USA an excellent alternative to established treatment methods.

(Not all products are approved in all markets; the approval markings and statements can vary from country to country. Please note the particular country website which contains additional product-specific information. Products are subject to changes to the design and scope of delivery of the products and further technical development.)